Pressmeddelande -

Pre-Diabetes Management, In obese patients using 532 nm laser to modify/correct the anticipated clinical outcomes

For further info contact Arch of Scandinavia AB

Treatment method

  • 20 laser treatments over 10 weeks
  • The target area was the tummy, and the anterolateral flanks (love handles).
  • Each treatment lasted 40 minutes with 20 minutes per area treated and a 5 minute rest period between applications.
  • Patients were also put on a mild ketogenic diet and overseen by a dietitian.
  • Normal research protocols applied. 


The clinic where these patients were treated is also a research facility, so

information is consistently gathered. This information fuels research and

clinical case studies such as this one. Laser is the treatment of choice for pre-diabetes management, obesity management, and pain management.

Average BMI Average Height Average age Average weight
40 5’9’’ (175cm) 51 15 st (95kg)
41 5’9’’1/2 41 14 st 9Lbs (93kg)
Female Male Total
71 69 140

With laser and diet, at the end of the 10 weeks, only 1 person was still considered to be a diabetic risk

With diet alone, 6 people were considered to no longer be a diabetic risk.

  • Diabetes is and will continue to be a world issue unless we educate and inform.
  • Diabetes is not just about diet.
  • Is diabetes is both a psychosocial/psychological problem as well as a medical one?
  • Laser is a viable option to managing pre-diabetes .
  • Is there a new role for clinicians in the management of diabetes.
  1. 1.Diabetes Blue Circle Symbol". International Diabetes Federation. 17 March 2006. Archived from the original on 5 August 2007.
  2. 2."Diabetes Fact sheet N°312". WHO. October 2013. Archived from the original on 26 August 2013. Retrieved 25 March 2014.
  3. 3.Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (July 2009). "Hyperglycemic crises in adult patients with diabetes". Diabetes Care. 32 (7): 1335–43. doi:10.2337/dc09-9032. PMC2699725  . PMID19564476.
  4. 4.Ripsin CM, Kang H, Urban RJ (January 2009). "Management of blood glucose in type 2 diabetes mellitus" (PDF). American Family Physician. 79 (1): 29–36. PMID19145963. Archived (PDF) from the original on 2013-05-05.
  5. 5."Update 2015". ID F. International Diabetes Federation. p. 13. Archived from the original on 22 March 2016. Retrieved 21 March 2016.
  6. 6."The top 10 causes of death Fact sheet N°310". World Health Organization. October 2013. Archived from the original on 30 May 2017.
  7. 7."About diabetes". World Health Organization. Archived from the original on 31 March 2014. Retrieved 4 April 2014.
  8. 8.Shoback DG, Gardner D, eds. (2011). "Chapter 17". Greenspan's basic & clinical endocrinology (9th ed.). New York: McGraw-Hill Medical. ISBN978-0-07-162243-1.
  9. 9.RSSDI textbook of diabetes mellitus (Rev. 2nd ed.). Jaypee Brothers Medical Publishers. 2012. p. 235. ISBN9789350254899. Archived from the original on 14 October 2015.
  10. 10.Rippe RS, Irwin JM, eds. (2010). Manual of intensive care medicine (5th ed.). Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 549. ISBN9780781799928.
  11. 11.Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ (September 2009). "The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation". Health Technology Assessment. 13 (41): 1–190, 215–357, iii–iv. doi:10.3310/hta13410. PMID19726018.

Relaterade länkar


  • Detaljhandel


  • archofscandinavia
  • övervikt
  • hälsa
  • obesitas
  • diabetes
  • erchonia

Arch of Scandinavia agerar för en intelligent och effektiv hälsovård. Science based, driven by change. 

Relaterat innehåll